Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

A low-starch/low-dairy diet may help overweight women with PCOS lose weight and improve metabolism, but more research is needed.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Young women with PCOS without additional risk factors may have normal heart function.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.